Bioengineered.2020 Dec;11(1):547-557.doi: 10.1080/21655979.2020.1765501.
2020-12-21Bioengineered.2020 Dec;11(1):547-557.doi: 10.1080/21655979.2020.1765501. miR-211 alleviates ischaemia/reperfusion-induced kidney injury by targeting TGFβR2/TGF-β/SMAD3 pathway. miR-211通过靶向TGFβR2/TGF-β/SMAD3途径减轻缺血/再灌注诱导的肾损伤